Related references
Note: Only part of the references are listed.Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel
Yoshimasa Miyagawa et al.
CLINICAL BREAST CANCER (2018)
Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy
Zhaoqing Du et al.
PLOS ONE (2018)
Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma
Kiyohiko Omichi et al.
SURGERY (2017)
Intrahepatic cholangiocarcinoma: current perspectives
Stefan Buettner et al.
ONCOTARGETS AND THERAPY (2017)
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Nader N. Massarweh et al.
CANCER CONTROL (2017)
Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic Cholangiocarcinoma
Kwangwoo Nam et al.
SCIENTIFIC REPORTS (2017)
Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety, Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival
Nathaniel C. Swinburne et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2017)
A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma
Tomoaki Yoh et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy
Ban Seok Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management
Han Zhang et al.
CANCER LETTERS (2016)
Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy
Hyerim Ha et al.
ONCOTARGET (2016)
Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
Guohe Lin et al.
ONCOTARGET (2016)
Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
Yoram S. Baum et al.
ASIAN JOURNAL OF UROLOGY (2016)
Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations
Lorena Marcano-Bonilla et al.
CHINESE CLINICAL ONCOLOGY (2016)
Association between Diabetes Mellitus and Fatty Liver Based on Ultrasonography Screening in the World's Highest Cholangiocarcinoma Incidence Region, Northeast Thailand
Kavin Thinkhamrop et al.
Asian Pacific Journal of Cancer Prevention (2015)
Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-Analysis
Kichang Han et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy
Qing Chen et al.
TUMOR BIOLOGY (2015)
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review
Hyo Jung Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Intrahepatic Cholangiocarcinoma: expert consensus statement
Sharon M. Weber et al.
HPB (2015)
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Intrahepatic Cholangiocarcinoma
Lucas M. Boehm et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features
Jau-Yu Liau et al.
MODERN PATHOLOGY (2014)
Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis
Tong-Chun Xue et al.
PLOS ONE (2014)
Hepatitis B virus infection and intrahepatic cholangiocarcinoma
Hua-Bang Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma - A single-center experience
U. Scheuermann et al.
EJSO (2013)
Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: Results of a large monocentric series
Z. F. Wu et al.
EJSO (2012)
Radiofrequency Ablation for the Treatment of Primary Intrahepatic Cholangiocarcinoma
Jin Hyoung Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma
S. -Y. Park et al.
CLINICAL RADIOLOGY (2011)
OEM-TACE: A New Therapeutic Approach in Unresectable Intrahepatic Cholangiocarcinoma
Guido Poggi et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2009)
Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma
Dhanwant Gomez et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Inflammation and cancer:: When NF-κB amalgamates the perilous partnership
MA Dobrovolskaia et al.
CURRENT CANCER DRUG TARGETS (2005)
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
YH Shaib et al.
JOURNAL OF HEPATOLOGY (2004)
The epidemiology of cholangiocarcinoma
Y Shaib et al.
SEMINARS IN LIVER DISEASE (2004)
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
T Patel
HEPATOLOGY (2001)
Share Paper
